Yunfei Zhu

This inventor holds 27 USPTO granted patents and 21 published patent applications and 9 EPO patents, primarily in Therapeutic Targeting. Top assignees: Crinetics Pharmaceuticals, Inc., Radionetics Oncology, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunfei Zhu. Retrieved from https://idiyas.com/inventor/yunfei-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 21)

% Patents Active = 92.6

EPO Patents = 9 (Patent Applications = 19)

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 108(Granted Patents)

Company Filing History:

25 out of 33

Crinetics Pharmaceuticals, Inc.

patents

2 out of 2

Radionetics Oncology, Inc.

patents

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Neuropeptide Y1 Receptor

Somatostatin Type 5 Receptor

Kisspeptin Receptor

Melanocortin Subtype-2 Receptor

Somatostatin Modulators

Therapeutics

Receptor Agonists

Receptor Antagonists

Drug Development

Pharmaceutical Research

Neuropeptides

Targeted Therapies

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12685789 - Neuropeptide Y1 receptor (NPY1R) targeted therapeutics and uses thereof (2026-07-21),

2. 12600709 - Nonpeptide somatostatin type 5 receptor agonists and uses thereof (2026-04-14),

3. 12521455 - KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF (2026-01-13),

4. 12492181 - Gem-disubstituted piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof (2025-12-09),

5. 12479828 - Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof (2025-11-25),

6. 12479825 - Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof (2025-11-25),

7. 12466829 - Spirocyclic piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof (2025-11-11),

8. 12134610 - Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof (2024-11-05),

9. 11834462 - Somatostatin modulators and uses thereof (2023-12-05),

10. 11608335 - Somatostatin modulators and uses thereof (2023-03-21),

11. 11566015 - Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof (2023-01-31),

12. 11479540 - Nonpeptide somatostatin type 5 receptor agonists and uses thereof (2022-10-25),

13. 11414397 - Somatostatin modulators and uses thereof (2022-08-16),

14. 11186590 - Somatostatin modulators and uses thereof (2021-11-30),

15. 11072598 - Somatostatin modulators and uses thereof (2021-07-27),

Title: Inventor Yunfei Zhu - Revolutionizing Technology in San Diego

Introduction: Yunfei Zhu is a pioneering inventor based in San Diego, CA, known for her groundbreaking contributions to the field of technology.

Latest Patents: Yunfei Zhu holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of expertise and innovation.

Career Highlights: With a background in engineering and a passion for innovation, Yunfei Zhu has led numerous successful projects that have pushed the boundaries of technological advancement. Her commitment to excellence and forward-thinking approach have earned her recognition in the industry.

Collaborations: Throughout her career, Yunfei Zhu has collaborated with leading research institutions, tech companies, and universities to further develop and implement her inventions. These partnerships have been instrumental in bringing her ideas to life and making a significant impact on the tech landscape.

Conclusion: Inventor Yunfei Zhu's relentless pursuit of innovation and her dedication to creating cutting-edge solutions have solidified her reputation as a trailblazer in the field of technology. Her work continues to inspire and shape the future of technological advancements.

Profile summary based on public USPTO records.